摘要
骨骼肌萎缩的特征是一种不受控制的炎症和氧化应激状态,会加剧蛋白质分解代谢。 最近的进展支持通过 toll 样受体 (TLR) 控制的肌肉纤维中的撞击信号分子。 激活的 TLR 信号通路已被确定为肌肉质量的抑制剂并引发肌肉萎缩。 其中,主要是TLR2和TLR4的存在,加剧了促炎细胞因子的释放,使同步的肌肉程序发生变形。 本综述阐明了 TLR 信号介导的肌肉损失以及炎症与骨骼肌生长之间的相互作用。
关键词: Toll 样受体、骨骼肌萎缩、炎症、氧化应激、促炎细胞因子。
Current Medicinal Chemistry
Title:Dynamics of Toll-like Receptors Signaling in Skeletal Muscle Atrophy
Volume: 28 Issue: 28
关键词: Toll 样受体、骨骼肌萎缩、炎症、氧化应激、促炎细胞因子。
摘要: Skeletal muscle atrophy has been characterized as a state of uncontrolled inflammation and oxidative stress that escalates protein catabolism. Recent advancement supports impinging signaling molecules in the muscle fibers controlled through toll-like receptors (TLR). Activated TLR signaling pathways have been identified as inhibitors of muscle mass and provoke the settings for muscle atrophy. Among them, mainly TLR2 and TLR4 manifest their presence to exacerbate the release of the pro-inflammatory cytokine to deform the synchronized muscle programming. The present review enlightens the TLR signaling mediated muscle loss and the interplay between inflammation and skeletal muscle growth.
Export Options
About this article
Cite this article as:
Dynamics of Toll-like Receptors Signaling in Skeletal Muscle Atrophy, Current Medicinal Chemistry 2021; 28 (28) . https://dx.doi.org/10.2174/0929867328666210202113734
DOI https://dx.doi.org/10.2174/0929867328666210202113734 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resurgence of Herbal Antihypertensives in Management of Hypertension
Current Hypertension Reviews Updated Electrocardiographic Classification of Acute Coronary Syndromes
Current Cardiology Reviews Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Current Pharmaceutical Design Stem Cell Engineering for the Treatment of Severe Hemoglobinopathies
Current Molecular Medicine Vitamin D/VDR in Acute Kidney Injury: A Potential Therapeutic Target
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Cardiology Reviews Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target
Current Drug Targets Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology Mechanisms and Medical Management of Exercise Intolerance in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design Functional Variants of the Interleukin-23 Receptor Gene in Non-Gastrointestinal Autoimmune Diseases
Current Medicinal Chemistry New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications
Current Radiopharmaceuticals MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress
Current Neurovascular Research Lone Atrial Fibrillation: Electrophysiology, Risk Factors, Catheter Ablation and Other Non-pharmacologic Treatments
Current Pharmaceutical Design A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy
Current Drug Delivery Cell Based Approaches for Myocardial Regeneration and Artificial Myocardium
Current Stem Cell Research & Therapy Understanding and Avoiding Antiretroviral Adverse Events
Current Pharmaceutical Design Intra-Renal Hemodynamic Changes After Habitual Physical Activity in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)
Current Vascular Pharmacology